adenosine and warfarin
adenosine has been researched along with warfarin in 37 studies
Research
Studies (37)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (24.32) | 18.7374 |
| 1990's | 1 (2.70) | 18.2507 |
| 2000's | 8 (21.62) | 29.6817 |
| 2010's | 19 (51.35) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cameron, JS; Clark, WF; George, CR | 1 |
| Katano, Y; Nakagawa, Y; Nakazawa, M; Takeda, K; Tsukada, T | 1 |
| Kang, HK; Shim, SC; Shin, EJ | 1 |
| Cho, TH; Shim, HK; Shim, SC | 1 |
| Hauser, M; Hönes, G; Hönes, J | 1 |
| Meyer, U; Raff, WK; Schiffer, W; Schulz, FW | 1 |
| Afonso, S; Hansing, CE; Rowe, GG | 1 |
| Grün, D; Grün, G; Hirche, H; Langohr, HD; Wacker, U | 1 |
| Hashimoto, K; Sano, N; Sato, S | 1 |
| Nitz, RE; Scholtholt, J; Schraven, E | 1 |
| Cho, HR; Choi, DH; Ju, SA; Kim, BS; Ko, BK; Lee, EA; Lee, JS; Lee, KA; Lee, SG; Lee, YJ; Nam, CW; Park, KM | 1 |
| Huang, LQ; Li, L; Xiao, YQ; Yang, B | 1 |
| Cramer, RD | 1 |
| Antz, M; Bänsch, D; Chen, M; Chun, J; Ernst, S; Falk, P; Hachiya, H; Khanedani, A; Kuck, KH; Ouyang, F; Schaumann, A | 1 |
| Bergendahl, V; Burgess, R; Goldfarb, A; Kozlov, M; Mustaev, A | 1 |
| Wang, LY; Wang, NL; Yao, XS | 1 |
| Cairns, JA; Eikelboom, JW; Hirsh, J; Paikin, JS | 1 |
| Mustonen, P; Puurunen, M | 1 |
| Reed, SD | 1 |
| Wenger, NK | 1 |
| Kiss, RG | 1 |
| Agewall, S; Andreotti, F; Atar, D; Cattaneo, M; Collet, JP; Grove, EL; Huber, K; Husted, S; Kjeldsen, K; Lip, GY; Morais, J; Pathak, A; Rosano, G; Storey, RF; Verheugt, FW; Wassmann, S | 1 |
| Alvarez, AI; Espín, JC; González-Sarrías, A; Lucas, R; Merino, G; Miguel, V; Morales, JC; Tomás-Barberán, F | 1 |
| Gupta, K; Singh, D; Vacek, JL | 1 |
| Adelakum, TA; Chang, YX; Gao, X; Ge, AH; He, J; Li, J; Liu, EW; Ma, WF; Wang, CP; Zhang, BL | 1 |
| Anderson, JL; Bates, ER; Bode, C; Granger, CB; Huber, K; Kristensen, SD; Lopez Sendon, JL; Ohman, EM; Steg, PG; Tubaro, M; Valgimigli, M; Wallentin, L | 1 |
| Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H | 1 |
| Chen, L; Fu, C; Lu, W; Ma, G; Wang, Y; Yao, Y; Zuo, P | 1 |
| Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ | 1 |
| Coons, JC; Iasella, CJ; Kane-Gill, SL; Verlinden, NJ | 1 |
| Bhatt, DL; Cannon, CP; Ellis, SG; Gropper, S; Harper, R; Hohnloser, SH; Januzzi, JL; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Manassie, J; Merkely, B; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Zeymer, U | 1 |
Reviews
9 review(s) available for adenosine and warfarin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The role of platelets in glomerulonephritis.
Topics: Adenosine; Antidepressive Agents; Aspirin; Blood Platelets; Complement System Proteins; Endothelium; Glomerulonephritis; Hemostasis; Heparin; Histamine H1 Antagonists; Humans; Immunity; Immunoglobulins; Indomethacin; Kidney Diseases; Meclofenamic Acid; Mopidamol; Phagocytosis; Phenylbutazone; Platelet Aggregation; Prostaglandins; Pyrimidines; Sulfinpyrazone; Tranquilizing Agents; Warfarin | 1975 |
New antithrombotic agents--insights from clinical trials.
Topics: Adenosine; Anticoagulants; Aspirin; Clopidogrel; Coronary Thrombosis; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine | 2010 |
[New antithrombotic drugs].
Topics: Adenosine; Anticoagulants; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2012 |
What's new in antiplatelet and anticoagulant therapy recommendations for unstable angina/non-ST-elevation myocardial infarction: 2012 focused update from the American College of Cardiology Foundation/American Heart Association task force on practice guide
Topics: Adenosine; Administration, Oral; Angina, Unstable; Anticoagulants; Evidence-Based Medicine; Hemorrhage; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Assessment; Risk Factors; Thiophenes; Ticagrelor; Treatment Outcome; Warfarin | 2012 |
[Novel agents for antithrombotic therapy in cardiology].
Topics: Adenosine; Administration, Oral; Anticoagulants; Aspirin; Clopidogrel; Coumarins; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Thiophenes; Thrombolytic Therapy; Ticagrelor; Ticlopidine | 2012 |
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy.
Topics: Adenosine; Aspirin; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic P2Y Receptor Antagonists; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2013 |
Anticoagulation and antiplatelet therapy in acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Enoxaparin; Fondaparinux; Heparin; Hirudins; Humans; Morpholines; Peptide Fragments; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Ticagrelor; Ticlopidine; Warfarin | 2014 |
Antiplatelet and anticoagulation agents in acute coronary syndromes: what is the current status and what does the future hold?
Topics: Acute Coronary Syndrome; Adenosine; Adenosine Monophosphate; Anticoagulants; Aspirin; Drug Therapy, Combination; Enoxaparin; Eptifibatide; Fondaparinux; Heparin; Hirudins; Humans; Lactones; Peptide Fragments; Peptides; Piperazines; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polysaccharides; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Recombinant Proteins; Thiophenes; Ticagrelor; Tirofiban; Tyrosine; Warfarin | 2014 |
Trials
3 trial(s) available for adenosine and warfarin
| Article | Year |
|---|---|
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS.
Topics: Adenosine; Adolescent; Adult; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Research Design; Ticagrelor; Ticlopidine; Warfarin; Young Adult | 2015 |
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.
Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin | 2015 |
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Topics: Adenosine; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Ticagrelor; Ticlopidine; Warfarin | 2017 |
Other Studies
25 other study(ies) available for adenosine and warfarin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Effects of aminophylline, proxyphylline and a proxyphylline-Melilotus extract-rutin mixture (theoesberiven) on the heart and the coronary circulation.
Topics: Adenosine; Aminophylline; Animals; Blood Volume; Cardiac Output; Coronary Circulation; Coumarins; Dogs; Dose-Response Relationship, Drug; Drug Combinations; Female; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardium; Oxygen; Oxygen Consumption; Plant Extracts; Rutin; Stimulation, Chemical; Theophylline | 1977 |
Transient absorption spectra and quenching of coumarin excited states by nucleic acid bases.
Topics: Adenine; Adenosine; Coumarins; Deoxyadenosines; Kinetics; Lasers; Molecular Structure; Photolysis; Thymidine; Thymine | 1992 |
Isolation and characterization of the photoadducts of 5,7-dimethoxycoumarin and adenosine.
Topics: Adenosine; Coumarins; Magnetic Resonance Spectroscopy; Mass Spectrometry; Spectrophotometry; Ultraviolet Rays | 1987 |
Studies of enzyme-ligand complexes using dynamic fluorescence anisotropy. II. The coenzyme-binding site of malate dehydrogenase.
Topics: Adenosine; Animals; Binding Sites; Chickens; Coumarins; Fluorescence Polarization; Humans; Malate Dehydrogenase; Mitochondria, Heart; NAD; Swine | 1986 |
[Proceedings: Coronary steal phenomenon in intracoronary infusion of adenosine, nitroglycerine, persantin, intensain and nifedipine].
Topics: Adenosine; Animals; Collateral Circulation; Coronary Circulation; Coumarins; Diethylamines; Dipyridamole; Dogs; Glycolates; Nitroglycerin; Vascular Resistance | 1974 |
Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
Topics: Adenosine; Aminophylline; Animals; Blood Pressure; Cardiac Output; Coronary Vessels; Coumarins; Dogs; Drug Interactions; Heart Atria; Heart Rate; Methyl Ethers; Morpholines; Myocardium; NAD; Oxygen; Oxygen Consumption; Pulmonary Artery; Time Factors; Vascular Resistance; Vasodilator Agents | 1973 |
The effect of carbocromen and dipyridamole on blood flow of the gastrocnemius of the dog.
Topics: Acetylcholine; Adenosine; Aminophylline; Animals; Blood Pressure; Coumarins; Diethylamines; Dipyridamole; Dogs; Electric Stimulation; Female; Glycolates; Injections, Intra-Arterial; Injections, Intravenous; Isoproterenol; Male; Muscles; Papaverine; Regional Blood Flow; Theophylline; Vasodilator Agents | 1974 |
Differences among dipyridamole, carbochromen and lidoflazine in responses of the coronary and the renal arteries.
Topics: Acetamides; Adenosine; Animals; Arrhythmias, Cardiac; Blood Pressure; Coronary Circulation; Coronary Vessels; Coumarins; Dipyridamole; Dogs; Drug Synergism; Female; Glycolates; Male; Norepinephrine; Piperazines; Regional Blood Flow; Renal Artery; Vasodilator Agents; Xylenes | 1972 |
On the mechanism of the antagonistic action of xanthine derivatives against adenosine and coronary vasodilators.
Topics: Acetamides; Adenosine; Animals; Blood Flow Velocity; Caffeine; Cell Membrane Permeability; Coronary Vessels; Coumarins; Dipyridamole; Dogs; Drug Interactions; Erythrocytes; Female; Glycolates; Humans; Male; Piperazines; Receptors, Drug; Structure-Activity Relationship; Theophylline; Vasodilator Agents; Xanthines; Xylenes | 1972 |
Cold preservation of rat cultured hepatocytes: the scoparone effect.
Topics: Adenosine; Alanine Transaminase; Allopurinol; Animals; Antihypertensive Agents; Cell Survival; Cold Temperature; Coumarins; Glutathione; Hepatocytes; Hypertonic Solutions; Insulin; Kinetics; Malondialdehyde; Organ Preservation Solutions; Raffinose; Rats; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Time Factors; Tissue Preservation; Vitamin E | 2000 |
[Studies on chemical constituents from root of Saposhnikovia divaricata (Turcz.) Schischk].
Topics: Adenosine; Apiaceae; Coumarins; Plant Roots; Plants, Medicinal | 2001 |
Topomer CoMFA: a design methodology for rapid lead optimization.
Topics: Adenosine; Coumarins; Dopamine Antagonists; Enzyme Inhibitors; Flavonoids; Indoles; Models, Molecular; Oligopeptides; Phenylalanine; Piperazines; Purinergic P1 Receptor Agonists; Pyridazines; Quantitative Structure-Activity Relationship; Receptors, Cannabinoid; Receptors, Drug; Receptors, GABA-A; Sulfonamides | 2003 |
Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation.
Topics: Adenosine; Aged; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Catheter Ablation; Combined Modality Therapy; Coronary Disease; Electrocardiography; Female; Follow-Up Studies; Heart Conduction System; Humans; Hypertension; Male; Middle Aged; Phlebography; Postoperative Complications; Prospective Studies; Pulmonary Veins; Recurrence; Tachycardia; Treatment Outcome; Warfarin | 2004 |
Homogeneous fluorescent assay for RNA polymerase.
Topics: Adenosine; Aminoglycosides; Combinatorial Chemistry Techniques; Coumarins; DNA-Directed RNA Polymerases; Enzyme Inhibitors; Heparin; Hymecromone; Rifampin; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2005 |
[Non-saponins from Solanum nigrum L].
Topics: Adenosine; Chromatography, High Pressure Liquid; Coumarins; Glucosides; Lignans; Molecular Structure; Parabens; Plants, Medicinal; Solanum nigrum | 2007 |
How country-specific should a country-specific cost-effectiveness analysis be?
Topics: Acute Coronary Syndrome; Adenosine; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticagrelor; Warfarin | 2013 |
The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
Topics: Adenosine; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Breast Neoplasms; Cattle; Cell Line, Tumor; Coumarins; Diketopiperazines; Dogs; Ellagic Acid; Female; Glucuronides; Heterocyclic Compounds, 4 or More Rings; Humans; Hydrolyzable Tannins; Madin Darby Canine Kidney Cells; Mice; Microbiota; Mitoxantrone; Neoplasm Proteins; Sheep; Sulfates | 2013 |
Ultra high performance liquid chromatography with photodiode array detector and quadrupole time-of-flight tandem mass spectrometry coupled with discriminant analysis to evaluate Angelicae pubescentis radix from different regions.
Topics: Adenosine; Apiaceae; Chromatography, High Pressure Liquid; Coumarins; Geographic Mapping; Hydroxybenzoates; Sesquiterpenes; Tandem Mass Spectrometry; Time Factors | 2014 |
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin | 2015 |
Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel.
Topics: Adenosine; Aged; Aspirin; Cohort Studies; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Ticagrelor; Warfarin | 2017 |